Mark Baer
Impact in
- Immunology top 5%
- Immune Response and Inflammation
- interferon and immune responses
- Immune cells in cancer
- Immune Cell Function and Interaction
- Cancer Research top 5%
- NF-κB Signaling Pathways
Papers in
-
- Immune Response and Inflammation 7
- Immune cells in cancer 3
- Co-authors
- Peter F. Johnson (10 shared papers)Richard C. Schwartz (7 shared papers)Simon C. Williams (6 shared papers)Allan Dillner (3 shared papers)Geoffrey Yarranton (8 shared papers)Christopher Bebbington (9 shared papers)Sergei A. Nedospasov (1 shared paper)Ulrich Siebenlist (1 shared paper)
- Journals
- Blood (6 papers)Journal of Biological Chemistry (5 papers)Molecular and Cellular Biology (3 papers)Journal of Cardiovascular Pharmacology (1 paper)Analytical Biochemistry (1 paper)
- Partner nations
- United StatesAustraliaFrance
In The Last Decade
Mark Baer
22 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 99
- Immunology 453
- Cancer Research 271
- Hematology 125
- Molecular Medicine 55
- Genetics 86
Countries citing papers authored by Mark Baer
This map shows the geographic impact of Mark Baer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Baer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Baer more than expected).
Fields of papers citing papers by Mark Baer
This network shows the impact of papers produced by Mark Baer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Baer. The network helps show where Mark Baer may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Baer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 172 | |
| 2 | 1998 | 161 | |
| 3 | 1997 | 123 | |
| 4 | 2013 | 111 | |
| 5 | 2008 | 95 | |
| 6 | 2000 | 85 | |
| 7 | Redundancy of C/EBP alpha, -beta, and -delta in supporting the lipopolysaccharide-induced transcription of IL-6 and monocyte chemoattractant protein-1. | 1998 | 85 |
| 8 | 1998 | 74 | |
| 9 | 2014 | 67 | |
| 10 | 2000 | 66 | |
| 11 | 2002 | 59 | |
| 12 | 2014 | 55 | |
| 13 | 1998 | 44 | |
| 14 | 2006 | 36 | |
| 15 | 1993 | 20 | |
| 16 | 2011 | 10 | |
| 17 | 2014 | 10 | |
| 18 | 1989 | 7 | |
| 19 | 2010 | 6 | |
| 20 | 2022 | 5 |
About Mark Baer
Mark Baer is a scholar working on Molecular Biology, Immunology, Cancer Research, Cellular and Molecular Neuroscience and Oncology, having authored 23 papers that have together received 1.3k indexed citations. Recurring topics across this work include Immune Response and Inflammation (7 papers), NF-κB Signaling Pathways (6 papers), Cytokine Signaling Pathways and Interactions (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Immune cells in cancer (3 papers), Acute Myeloid Leukemia Research (3 papers), Axon Guidance and Neuronal Signaling (2 papers) and Light effects on plants (2 papers). The work is most often cited by research in Immunology (453 citations), Cancer Research (271 citations), Hematology (125 citations), Molecular Medicine (55 citations) and Genetics (86 citations). Mark Baer has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Peter F. Johnson, Richard C. Schwartz, Simon C. Williams, Allan Dillner, Geoffrey Yarranton, Christopher Bebbington, Sergei A. Nedospasov, Ulrich Siebenlist, Keith Brown and Estefanı́a Claudio. Their work appears in journals such as Blood, Journal of Biological Chemistry, Molecular and Cellular Biology, Journal of Cardiovascular Pharmacology and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.